Released May 8, 2017, before the open
10-Q filed May 8, 2017, 38 days after period end · 0001144204-17-024996
Q1 2017 · 10-Q
Revenue$684.00K$684.00K no prior Q1 2016 on fileno prior Q4 2016 on file
Net Income-$13.93M-$13.93M N/M vs Q1 2016N/M vs Q4 2016
EPS Diluted-$810.00-$810.00 N/M vs Q1 2016N/M vs Q4 2016
Operating Income-$13,929,829N/M
Operating Cash Flow$34,944,909N/M
Free Cash Flowderived$34,944,909N/M
Margins · derived
Operating margin-2036.5%
Net margin-2036.7%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $684.00K | — | — | — |
| Net Income | -$13.93M | -$10.99M | -$7.14M | -$4.07M |
| EPS Diluted | -$810.00 | -$0.64 | -$0.64 | -$0.92 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR